IDBS Polar

Explore the challenges of technology transfer in biopharmaceutical development and the critical role of digital transformation in bridging data and knowledge gaps. Learn how centralized, compliant data platforms help organizations improve collaboration, ensure data integrity, and maintain visibility across internal teams, manufacturing sites, and external partners. Discover how digital process and product knowledge management can accelerate commercialization, reduce risk, and support efficient technology transfer throughout the product lifecycle.

Resource details:

Resource type: Infographic
Page count: 5
Read time: 8 mins

Explore how IDBS Polar helps organizations plan, execute and analyze stability studies within a single, connected platform. Learn how protocol-driven scheduling, traceable workflows, and real-time visibility into study progress can reduce missed pulls, minimize rework, and accelerate reporting. Discover how centralized stability management supports inspection readiness, strengthens governance, and ensures continuity across the entire stability study lifecycle while maintaining compliance with GxP requirements.

Resource details:

Resource type: Flyer
Page count: 1
Read time: 2 min

This flyer introduces IDBS Polar Control, a process lifecycle management solution designed to help biopharmaceutical organizations capture, manage and optimize process knowledge throughout drug development. Learn how the platform centralizes parameter control, process documentation and lifecycle management to improve data continuity, accelerate technology transfer, and, and process standardization can reduce risk, improve quality, and drive more efficient development and manufacturing outcomes.

Resource details:

Resource type: Flyer
Page count: 1
Read time: 2 mins

This case study explores how a global biosimilars company transformed laboratory data management using IDBS Polar to standardize workflows, integrated over 350 instruments and systems, and improved data integrity. Discover how the implementation reduced manual transcription errors by approximately 50%, accelerated digital adoption across more than 400 users, and enabled faster, data-driven decision-making through contextualized laboratory data.

Resource details:

Resource type: Case study
Page count: 4
Read time: 6 mins

This infographic highlights the top 10 benefits of migrating from on-premises systems to IDBS Polar cloud technology. Learn how cloud deployment can enhance security, scalability, disaster recovery, collaboration, and regulatory compliance while reducing IT maintenance demands. Discover how organizations can accelerate innovation, improve operational agility, support sustainability initiatives, and achieve high service uptime through a secure, expertly managed cloud environment designed for life sciences and research workflows.

Resource details:

Resource type: Infographic
Page count: 2
Read time: 3 mins

Friday, November 13 at 16:30 GMT | 17:30 CET | 11:30 EST | 08:30 PST

When a process begins to behave differently, CMC teams need to understand why. They need to investigate potential causes, determine which parameters may be affecting product quality, generate evidence to reach a decision, and retain the scientific rationale behind what happens next.

Join Marc Smith, Value Stream Director at IDBS to see how IDBS Polar supports this workflow in practice. Starting with multi-batch process data, the demonstration will follow an observed shift in a critical quality attribute through investigation and risk assessment, into a small-scale design of experiments (DoE) study to understand the parameters influencing process performance.

The resulting evidence remains connected to the evolving process definition as operating ranges and parameter classifications are reviewed, necessary process updates are made and their impact is confirmed.

By connecting investigation, experimental evidence and decisions, CMC teams can preserve how and why the process evolved, keeping that knowledge available for future use across process development, technology transfer and regulatory filings, while creating a stronger foundation for emerging applications such as AI.

Certificate of attendance
If you attend the live TechTalk, you will automatically receive a certificate of attendance, including a learning outcomes summary, for continuing education purposes. If you view the on-demand TechTalk, you can request a certificate of attendance by emailing editor@selectscience.net.

TechTalk details

• Cost: Free to attend
• Location: Online
• Duration: 20 minutes

Registration is required to secure your place. If you register but can’t attend live, you will receive a link to the on‑demand recording once it becomes available.

Monday, November 2 at 16:00 GMT | 17:00 CET | 11:00 EST | 08:00 PST

Why do chemistry, manufacturing and controls (CMC) and regulatory teams still spend significant time searching for evidence, validating historical decisions, and reconstructing the scientific rationale behind established processes?

The problem is rarely a complete absence of data. More often, the connections between product requirements, experiments, risk assessments, process parameters and scientific decisions have weakened as information moves through development, scale-up and technology transfer. By the time Module 3 preparation begins, teams may be able to find the final value without being able to readily recover why it was selected or how it was justified.

In this SelectScience® webinar, Ken Forman, Lead Product Manager at IDBS, and Mark Buswell, Director of AMB Engineering and Technology and former Vice President at GSK, will explore how organizations can make submission readiness an outcome of the development process rather than a retrospective evidence-reconstruction exercise.

Drawing on experience spanning preclinical research, analytical development and global system implementation, the speakers will examine where valuable knowledge and scientific context are most at risk across the product lifecycle. They will also discuss which connections need to remain intact so that teams can prepare Module 3 documentation and clearly explain why established processes and parameters were selected.

By attending this webinar, you will gain practical insights into strengthening continuity across CMC, maintaining traceability between scientific evidence and decisions, and making submission evidence easier to reuse, interpret and defend.

Certificate of attendance

If you attend the live webinar, you will automatically receive a certificate of attendance, including a learning outcomes summary, for continuing education purposes.

If you view the on-demand webinar, you can request a certificate of attendance by emailing editor@selectscience.net.

Webinar details

Cost: Free to attend

Location: Online

Duration: 60 minutes

Registration is required to secure your place. If you register but can’t attend live, you will receive a link to the on‑demand recording once it becomes available.

IDBS and Alchemi partner to combine compliant AI agents with governed biopharma data for faster regulatory submissions

IDBS highlights customer successes and key innovations that advanced scientific digital transformation

Vantive’s commitment to innovation, powered by Polar, positions the company as a forward-thinking leader in vital organ therapy

Polar Control is set to redefine how biopharmaceutical companies manage and evolve their processes